Attovia Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire•27/10/2026•16:05 ET
0
Key Highlights
- ➤Attovia management to participate in three healthcare investor conferences in November 2026
- ➤Guggenheim fireside chat scheduled for November 10, 2026, at 3:30 PM ET
- ➤Stifel conference includes one-on-one investor meetings on November 11, 2026
- ➤Jefferies Global Healthcare Conference meetings run November 16–18, 2026
- ➤Lead programs include ATTO-1310, ATTO-2306, and ATTO-1091 in clinical or IND-enabling development
SAN CARLOS, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia” or the “Company”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today announced that company management will participate in the following upcoming investor conferences:
Guggenheim 3(rd) Annual Healthcare Innovation Conference Format: Fireside chat Date: Tuesday, November 10, 2026 Time: 3:30 PM - 3:55 PM ET
Get started
Create a free account to read the full story.